Cargando…

COVID19 associated mucormycosis: Is GRP78 a possible link?

This review aimed to study molecular mechanisms for high incidence of life-threatening mucormycosis infection in COVID19 cases during second wave of SARS CoV2 pandemic in India. Hyperglycaemia, impaired immunity, acidosis, raised ferritin, glucocorticoid therapy, and COVID19 specific other factors h...

Descripción completa

Detalles Bibliográficos
Autores principales: Gumashta, Jyotsna, Gumashta, Raghvendra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431836/
https://www.ncbi.nlm.nih.gov/pubmed/34538732
http://dx.doi.org/10.1016/j.jiph.2021.09.004
_version_ 1783751029871869952
author Gumashta, Jyotsna
Gumashta, Raghvendra
author_facet Gumashta, Jyotsna
Gumashta, Raghvendra
author_sort Gumashta, Jyotsna
collection PubMed
description This review aimed to study molecular mechanisms for high incidence of life-threatening mucormycosis infection in COVID19 cases during second wave of SARS CoV2 pandemic in India. Hyperglycaemia, impaired immunity, acidosis, raised ferritin, glucocorticoid therapy, and COVID19 specific other factors have been implicated in pathogenesis of COVID19 associated mucormycosis (CAMM). Endoplasmic reticulum chaperone ‘Glucose Related Protein 78' (GRP78), also involved in SARS CoV2 entry, is the host receptor for invasion by Mucorales. GRP78 is over-expressed by SARS CoV2, hyperglycaemia and ferritin. Delta variant of SARS CoV2 and indiscriminate use of steroids were distinguishing features of second wave and appear to upregulate GRP78 through intricate interplay between internal and external milieu. Common invasive fungal infections like candidiasis and aspergillosis, not utilizing GRP78 as receptor, were inconspicuous. Further molecular research to unravel mechanisms involved in the pathogenesis of CAMM shall effectively complement existing strategies for its prevention and treatment.
format Online
Article
Text
id pubmed-8431836
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Authors. Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.
record_format MEDLINE/PubMed
spelling pubmed-84318362021-09-10 COVID19 associated mucormycosis: Is GRP78 a possible link? Gumashta, Jyotsna Gumashta, Raghvendra J Infect Public Health Review This review aimed to study molecular mechanisms for high incidence of life-threatening mucormycosis infection in COVID19 cases during second wave of SARS CoV2 pandemic in India. Hyperglycaemia, impaired immunity, acidosis, raised ferritin, glucocorticoid therapy, and COVID19 specific other factors have been implicated in pathogenesis of COVID19 associated mucormycosis (CAMM). Endoplasmic reticulum chaperone ‘Glucose Related Protein 78' (GRP78), also involved in SARS CoV2 entry, is the host receptor for invasion by Mucorales. GRP78 is over-expressed by SARS CoV2, hyperglycaemia and ferritin. Delta variant of SARS CoV2 and indiscriminate use of steroids were distinguishing features of second wave and appear to upregulate GRP78 through intricate interplay between internal and external milieu. Common invasive fungal infections like candidiasis and aspergillosis, not utilizing GRP78 as receptor, were inconspicuous. Further molecular research to unravel mechanisms involved in the pathogenesis of CAMM shall effectively complement existing strategies for its prevention and treatment. The Authors. Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. 2021-10 2021-09-10 /pmc/articles/PMC8431836/ /pubmed/34538732 http://dx.doi.org/10.1016/j.jiph.2021.09.004 Text en © 2021 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Review
Gumashta, Jyotsna
Gumashta, Raghvendra
COVID19 associated mucormycosis: Is GRP78 a possible link?
title COVID19 associated mucormycosis: Is GRP78 a possible link?
title_full COVID19 associated mucormycosis: Is GRP78 a possible link?
title_fullStr COVID19 associated mucormycosis: Is GRP78 a possible link?
title_full_unstemmed COVID19 associated mucormycosis: Is GRP78 a possible link?
title_short COVID19 associated mucormycosis: Is GRP78 a possible link?
title_sort covid19 associated mucormycosis: is grp78 a possible link?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431836/
https://www.ncbi.nlm.nih.gov/pubmed/34538732
http://dx.doi.org/10.1016/j.jiph.2021.09.004
work_keys_str_mv AT gumashtajyotsna covid19associatedmucormycosisisgrp78apossiblelink
AT gumashtaraghvendra covid19associatedmucormycosisisgrp78apossiblelink